Specialized therapies in targeted indications
Merck Serono is committed to making a real difference in the lives of patients with selected endocrine and metabolic disorders. We do this through our unique offering of specialized therapies in targeted indications along with innovative drug delivery devices designed to maximize their full potential.
We are applying our expertise to treat growth hormone deficiency in children and adults, as well as other related metabolic disorders. In the United States, our growth hormone is helping patients with HIV-associated wasting and short bowel syndrome.
We have demonstrated our commitment to a rare metabolic disorder with a breakthrough therapy that allows those afflicted to lead a more normal life. In all of these areas, we are guided by our commitment to making a difference in the lives of patients and the people who care for them.